|
|
| We offer: |
| • |
Development/restructuring of
market access strategies |
| • |
Value lever and risk/benefit analysis |
| • |
Value proposition and value story development |
| • |
Market access expert panels |
| • |
Market access planning. |
| Recent projects: |
| • |
Development and validation
of EU-relevant value propositions for a range of primary/secondary
care and orphan drugs |
| • |
Enrichment of the value strategy of
a breakthrough biological through service-orientated
tools |
| • |
Audit of functional plans to identify/prioritise
gaps and recommendations for the EU market access plan
for a specialist drug. |
|
|
|